Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,779 | 14,037 | 5,774 | 19,065 | 28,640 |
| Marketable Securities | 10,305 | 10,325 | 20,838 | 43,038 | 39,348 |
| Receivables | 222 | 99 | 8,463 | 283 | 12,453 |
| Other current assets | 684 | 1,201 | 1,616 | 1,344 | 1,397 |
| TOTAL | $17,990 | $25,662 | $36,691 | $63,730 | $81,838 |
| Non-Current Assets | |||||
| PPE Net | 208 | 254 | 288 | 11,483 | 11,336 |
| Investments And Advances | 9,213 | 10,125 | 12,485 | 2,296 | 2,295 |
| Intangibles | 3,208 | 3,208 | 3,208 | 3,208 | 3,208 |
| Other Non-Current Assets | 83 | 102 | 103 | 344 | 344 |
| TOTAL | $12,712 | $13,689 | $16,084 | $17,331 | $17,183 |
| Total Assets | $30,702 | $39,351 | $52,775 | $81,061 | $99,021 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,005 | 9,704 | 16,787 | 18,971 | 10,343 |
| Accrued Expenses | 1,018 | 864 | 1,114 | 1,254 | 1,109 |
| TOTAL | $8,607 | $12,063 | $19,458 | $21,411 | $12,483 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,464 | 1,495 | 1,557 | 1,023 | 1,031 |
| Other Non-Current Liabilities | 4,139 | 4,160 | 4,183 | 4,206 | 4,229 |
| TOTAL | $21,774 | $22,122 | $22,472 | $15,228 | $15,414 |
| Total Liabilities | $30,381 | $34,185 | $41,930 | $36,639 | $27,897 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 45,355 | 45,076 | 43,696 | 43,746 | 43,651 |
| Common Shares | 45 | 45 | 44 | 44 | 44 |
| Retained earnings | -327,348 | -320,507 | -312,810 | -279,037 | -249,013 |
| Other shareholders' equity | -357 | -357 | -357 | -357 | -357 |
| TOTAL | $321 | $5,166 | $10,845 | $44,422 | $71,124 |
| Total Liabilities And Equity | $30,702 | $39,351 | $52,775 | $81,061 | $99,021 |